ReviewRheumatic diseases clinics of North America2008
Scleroderma-like fibrosing disorders.
Review in Rheumatic diseases clinics of North America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Scleredema Adultorum of Buschke Associated With Diffuse Eosinophilia and Hepatitis B Virus Infection.Cureus · 2023Article
- Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy.The American journal of case reports · 2021Article
- Review
- Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2.The Journal of investigative dermatology · 2019Article
- [Scleredema adultorum : Clinical presentation, diagnostic workup, differential diagnosis, treatment option].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018Review
- Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.Immunologic research · 2017Review
- Reactive oxygen species and fibrosis: further evidence of a significant liaison.Cell and tissue research · 2016Review
- Pathophysiology of gadolinium-associated systemic fibrosis.American journal of physiology. Renal physiology · 2016Review
- Scleroderma Mimickers.Current treatment options in rheumatology · 2016Article
- Face and neck swelling in a 16-year-old boy.BMJ case reports · 2012Article
- Eosinophilic fasciitis: what matters in management in a developing country--a case report with two and a half-year follow-up.Journal of health, population, and nutrition · 2012Article
- Nephrogenic systemic fibrosis.Indian dermatology online journal · 2011Article
- Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study.Arthritis research & therapy · 2011Article
- Nephrogenic systemic fibrosis: current concepts.Indian journal of dermatology · 2011Article
- Immunotherapy of systemic sclerosis.Immunotherapy · 2010Review
- Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.Rheumatology international · 2010Article
- Unusual presentation of eosinophilic fasciitis: two case reports and a review of the literature.Journal of medical case reports · 2010Article
- Resolution of pansclerotic morphea after treatment with antithymocyte globulin.Nature reviews. Rheumatology · 2009Article
- [Scleroderma and fibrosing diseases].Zeitschrift fur Rheumatologie · 2009Review
- Long-term benefit of electron beam radiation therapy in the treatment of scleredema of Buschke.Advances in radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Many conditions presenting with clinical hard skin and tissue fibrosis can be confused with systemic sclerosis (scleroderma). These disorders have very diverse etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow one to distinguish these conditions from scleroderma and from each other. A prompt diagnosis is important to spare patients from ineffective treatments and inadequate management. This article highlights nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy), eosinophilic fasciitis (Shulman's syndrome), scleromyxedema, and scleredema. These often are detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.